Ningbo Medical System Biotechnology Co., Ltd. is a high-technology enterprise specializing in the research, production, sales and service of a wide range of bio-tech products. Jointly invested by overseas-educated scholars and domestic experts in 2003, the company has also established its own R&D center in San Diego, U.S.A. Located in YinZhou Central District of Ningbo, Zhejiang province, the company is ranked as a hi-tech enterprise of both municipal and provincial level. Besides, Ningbo Medicalsystem Biotechnology has passed the certification of ISO9001:2000 and ISO13485:2003. In 2006, the company was awarded National Model of Sanitary-conditioned Enterprise, and in 2008,it was evaluated as National High-tech Enterprise.

  Ever since its foundation, the company has consistently adhered to the aim of creating a people-oriented and innovation-driven enterprise. Strictly abiding by GMP standard, its independently developed IVD reagent now takes a leading position in the domestic market. In addition, the introduction of the testing method using bilirubin has enabled the company to fill the gap between home and abroad. What’s more, its trial on the application of 3a-HSD in TBA testing with enzymatic cycling has been approved as a municipal-level project of high technology. Recently, the company developed enzyme detection reagent of glycosylated hemoglobin, a novelty that pioneers the domestic industry and gains the national fund for innovation. So far, its β2-microglobulin,TBA of enzyme circulation method ,bilirubin of chemistry oxidation detection, antistreptolycin O, rheumatoid factor, hypersensitivity C reactive protein, creatinine detection reagent are all enlisted as new products of Ningbo city. The newly developed cystine C (CYS-C), new stable CO2 single reagent, enzymatic glycosylated hemoglobin (HbA1c), as well as alpha-fetoprotein (AFP) and so on, can be used in various automatic biochemical analyzers. Due to the convenient usage, reliable quality, resonate price, these products are in leading place at home.

  Up to now, the company’s business is booming fast. To cope with the rapid pace of development, liaison offices and sales representatives have been established in over 10 major provinces and cities like Beijing, Shanghai, Guangdong, Zhejiang, Jiangsu, etc. so as to better serve the needs of our customers. Viewing the future, Ningbo Medical System Biotechonology will continuously devote itself to the supply of quality products and services, not simply for the cause of China’s clinical diagnosis, but also for the health of the Chinese people.

  Now, the company has purchased a land in YinZhou District with investment of RMB 30 million. The manufacture facility will be completed in 2008, and put into use in 2009 as planned, which occupy a land area of 10000 square meters. The company will provide high-quality product and excellent after-sale service to repay the support from our customers.